EUVIMEDEUVIMED entdecken
Crossref

Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis

Rahul Sharma, Ernest Debbarma, Susanta Ghanta

Journal of the Indian Chemical Society · 2026-11 · 103227

DOI: 10.1016/j.jics.2026.103227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Indian Chemical Society, 2026-11. Verfasst von Rahul Sharma und 2 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sharma, R., Debbarma, E., & Ghanta, S. (2026). Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis. Journal of the Indian Chemical Society, 103227. https://doi.org/10.1016/j.jics.2026.103227

Vancouver

Sharma R, Debbarma E, Ghanta S. Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis. Journal of the Indian Chemical Society. 2026:103227. doi:10.1016/j.jics.2026.103227

BibTeX
@article{Sharma2026,
  author = {Sharma, Rahul and Debbarma, Ernest and Ghanta, Susanta},
  title = {Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis},
  journal = {Journal of the Indian Chemical Society},
  year = {2026},
  pages = {103227},
  doi = {10.1016/j.jics.2026.103227}
}
Kostenlos starten →